Related Experiment Video
Updated: Aug 13, 2026
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes
C Suzuki1, M Unoki, Y Nakamura
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Japan.
Abstract:
Defects in the activity of the PTEN gene, a tumor suppressor, are implicated in many types of cancer in humans. However, not all mediators of PTEN signaling pathways have been clarified, and, during efforts to identify such molecules, we previously induced expression of the DUSP1 and BTG1 genes by introducing exogenous PTEN into endometrial cancer cell lines. In the course of analyzing these two genes for mutations in ovarian carcinomas, we identified a novel single-nucleotide polymorphism (SNP) in the DUSP1 gene, and three novel SNPs in the BTG1 gene, and we have established their allelic frequencies in a Japanese population sample. These polymorphic sites will be useful for detecting losses of heterozygosity (LOH) in tumors and for examining latent associations between specific alleles and disease susceptibility.
Insights
Researchers identified novel genetic variations in DUSP1 and BTG1 genes in ovarian cancer patients. These single-nucleotide polymorphisms (SNPs) may help detect tumor mutations and understand cancer susceptibility.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The PTEN gene is a crucial tumor suppressor implicated in human cancers.
- PTEN signaling pathways are not fully understood, necessitating the identification of key mediators.
- Previous research induced DUSP1 and BTG1 gene expression by introducing PTEN into endometrial cancer cells.
Purpose of the Study:
- To identify novel genetic variations within the DUSP1 and BTG1 genes.
- To determine the allelic frequencies of these variations in a Japanese population.
- To assess the utility of these polymorphic sites in cancer research.
Main Methods:
- Analysis of DUSP1 and BTG1 genes for mutations in ovarian carcinomas.
- Identification and characterization of novel single-nucleotide polymorphisms (SNPs).
- Determination of allelic frequencies in a Japanese population sample.
Main Results:
- A novel single-nucleotide polymorphism (SNP) was identified in the DUSP1 gene.
- Three novel SNPs were identified in the BTG1 gene.
- Allelic frequencies for these novel SNPs were established in a Japanese population.
Conclusions:
- The identified polymorphic sites in DUSP1 and BTG1 are valuable tools for detecting loss of heterozygosity (LOH) in tumors.
- These SNPs can be used to investigate potential associations between specific alleles and cancer susceptibility.
- Further research can leverage these findings to enhance understanding of PTEN pathway-related cancers.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs